Revvity Inc. $RVTY Shares Bought by Timber Creek Capital Management LLC

Timber Creek Capital Management LLC lifted its position in shares of Revvity Inc. (NYSE:RVTYFree Report) by 9.6% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 65,159 shares of the company’s stock after purchasing an additional 5,692 shares during the quarter. Revvity comprises approximately 1.4% of Timber Creek Capital Management LLC’s holdings, making the stock its 27th largest holding. Timber Creek Capital Management LLC owned approximately 0.06% of Revvity worth $5,711,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. CYBER HORNET ETFs LLC acquired a new stake in shares of Revvity in the second quarter worth $32,000. MUFG Securities EMEA plc acquired a new stake in Revvity in the 2nd quarter valued at $34,000. CVA Family Office LLC raised its position in Revvity by 79.0% in the second quarter. CVA Family Office LLC now owns 410 shares of the company’s stock valued at $40,000 after purchasing an additional 181 shares during the period. Headlands Technologies LLC acquired a new position in shares of Revvity during the second quarter worth about $49,000. Finally, Smartleaf Asset Management LLC boosted its position in shares of Revvity by 56.8% in the third quarter. Smartleaf Asset Management LLC now owns 690 shares of the company’s stock worth $58,000 after buying an additional 250 shares during the period. Institutional investors and hedge funds own 86.65% of the company’s stock.

Revvity Stock Up 0.5%

Shares of NYSE:RVTY opened at $96.01 on Tuesday. The company’s fifty day moving average is $103.49 and its two-hundred day moving average is $95.85. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.40 and a current ratio of 1.68. Revvity Inc. has a 1-year low of $81.36 and a 1-year high of $120.39. The stock has a market capitalization of $10.89 billion, a price-to-earnings ratio of 46.16, a price-to-earnings-growth ratio of 2.04 and a beta of 1.06.

Revvity (NYSE:RVTYGet Free Report) last announced its quarterly earnings data on Monday, February 2nd. The company reported $1.70 earnings per share for the quarter, beating analysts’ consensus estimates of $1.55 by $0.15. Revvity had a net margin of 8.45% and a return on equity of 7.92%. The business had revenue of $772.06 million during the quarter, compared to the consensus estimate of $759.81 million. During the same quarter in the prior year, the firm earned $1.42 EPS. The company’s revenue for the quarter was up 5.9% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. Equities analysts anticipate that Revvity Inc. will post 4.94 EPS for the current year.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 8th. Stockholders of record on Friday, April 17th will be issued a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, April 17th. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. Revvity’s payout ratio is 13.46%.

Revvity declared that its board has approved a stock repurchase program on Monday, October 27th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the company to reacquire up to 8.7% of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s management believes its shares are undervalued.

Wall Street Analyst Weigh In

RVTY has been the subject of several recent research reports. TD Cowen reaffirmed a “hold” rating on shares of Revvity in a research report on Tuesday, February 3rd. Barclays raised their price target on shares of Revvity from $115.00 to $118.00 and gave the company an “overweight” rating in a report on Tuesday, February 3rd. Evercore boosted their price objective on shares of Revvity from $112.00 to $118.00 and gave the stock an “outperform” rating in a report on Tuesday, February 3rd. Wells Fargo & Company upped their price objective on shares of Revvity from $107.00 to $110.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 3rd. Finally, JPMorgan Chase & Co. lifted their target price on Revvity from $100.00 to $105.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 3rd. Five investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $113.67.

Read Our Latest Report on RVTY

About Revvity

(Free Report)

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.

Featured Stories

Institutional Ownership by Quarter for Revvity (NYSE:RVTY)

Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.